Literature DB >> 29051031

Inflammatory molecules and neurotrophic factors as biomarkers of neuropsychomotor development in preterm neonates: A Systematic Review.

Rafael C Magalhães1, Letícia P Pimenta2, Izabela G Barbosa3, Janaina M Moreira4, João L V M de Barros5, Antônio L Teixeira6, Ana C Simões E Silva7.   

Abstract

OBJECTIVE: To provide a systematic review investigating the role of inflammatory molecules and neurotrophic factors as biomarkers of neuropsychomotor development in preterm neonates. DATA SOURCE: Databases including PubMed, BIREME, and Scopus were systematically searched. Observational studies, as well as transversal, and cohort studies using human subjects published from 1990 to September 2017 were eligible for inclusion. Two authors independently identified eligible studies and analyzed their characteristics, quality, and accuracy in depth. DATA SYNTHESIS: 11 eligible studies clearly investigated the association between peripheral inflammation and motor and/or cognitive development in preterm infants. However, the selected populations differed in relation to the events associated with prematurity and the risk factors to abnormal motor and/or cognitive development. These studies measured circulating levels of cytokines, chemokines, adhesion molecules, acute phase proteins, and growth factors. The most commonly analyzed proteins were IL-1β, IL-6, TNF, CCL5/RANTES, CXCL8/IL-8, IGFBP-1, and VEGF. In seven of the eligible studies, plasma levels of IL-6 correlated with development delay. Two studies reported correlation between CXCL8/IL-8 plasma levels with cognitive and motor delay. In one study, higher levels of MCP-1/CCL2 were associated with better cognitive and motor outcome.
CONCLUSION: There is preliminary evidence indicating that circulating inflammatory molecules are associated with motor and cognitive development in preterm neonates, even considering different populations.
Copyright © 2017 ISDN. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive development; Cytokines; Inflammation; Motor development; Neurotrophic factors; Preterm

Mesh:

Substances:

Year:  2017        PMID: 29051031     DOI: 10.1016/j.ijdevneu.2017.10.006

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  5 in total

1.  TNAP-a potential cytokine in the cerebral inflammation in spastic cerebral palsy.

Authors:  Xiao-Kun Wang; Chao Gao; He-Quan Zhong; Xiang-Yu Kong; Rui Qiao; Hui-Chun Zhang; Bai-Yun Chen; Yang Gao; Bing Li
Journal:  Front Mol Neurosci       Date:  2022-09-14       Impact factor: 6.261

2.  Neurotrophic Factor Levels in Preterm Infants: A Systematic Review and Meta-Analysis.

Authors:  Francieli Cristina Krey; Bruna Alvim Stocchero; Kerstin Camile Creutzberg; Bernardo Aguzzoli Heberle; Saulo Gantes Tractenberg; Li Xiang; Wei Wei; Bruno Kluwe-Schiavon; Thiago Wendt Viola
Journal:  Front Neurol       Date:  2021-04-01       Impact factor: 4.003

3.  Acupuncture accelerates neural regeneration and synaptophysin production after neural stem cells transplantation in mice.

Authors:  Lan Zhao; Jian-Wei Liu; Bo-Hong Kan; Hui-Yan Shi; Lin-Po Yang; Xin-Yu Liu
Journal:  World J Stem Cells       Date:  2020-12-26       Impact factor: 5.326

4.  Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life.

Authors:  Sara Poletti; Mariagrazia Palladini; Mario Gennaro Mazza; Rebecca De Lorenzo; Roberto Furlan; Fabio Ciceri; Patrizia Rovere-Querini; Francesco Benedetti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-10-26       Impact factor: 5.760

5.  The landscape of cognitive function in recovered COVID-19 patients.

Authors:  Hetong Zhou; Shaojia Lu; Jingkai Chen; Ning Wei; Dandan Wang; Hailong Lyu; Chuan Shi; Shaohua Hu
Journal:  J Psychiatr Res       Date:  2020-06-30       Impact factor: 4.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.